Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Abstract | Full HTML Article | PDF ecancer 13 982 / https://doi.org/10.3332/ecancer.2019.982


Is there any benefit to particles over photon radiotherapy?

Particle, essentially, proton radiotherapy (RT) could provide some benefits over photon RT, especially in reducing the side effects of RT. We performed a systematic review to identify the performed randomised clinical trials (RCTs) and ongoing RCTs comparing particle RT with photon therapy. So far, there are no results available from phase 3 RCTs comparing particle RT with photon therapy. Furthermore, the results on side effects comparing proton and carbon ion beam RT with photon RT do vary. The introduction of new techniques in photon RT, such as image-guided RT (IGRT), intensity-modulated RT (IMRT), volumetric arc therapy (VMAT) and stereotactic body RT (SBRT) was already effective in reducing side effects. At present, the lack of evidence limits the indications for proton and carbon ion beam RTs and makes the particle RT still experimental.

Keywords: hadron, particles radiotherapy, proton, carbon ion beam, cancer



Loading Article Metrics ... Please wait

Related articles

Clinical Study: Computational analyses on genetic alterations in the NSD genes family and the implications for colorectal cancer development

Abstract | Full Article | PDF Published: 15 Jan 2020 / https://doi.org/10.3332/ecancer.2020.1001

Research: The clinical-care focused psychological interview (CLiC): a structured tool for the assessment of cancer patients’ needs

Abstract | Full Article | PDF Published: 13 Jan 2020 / https://doi.org/10.3332/ecancer.2020.1000

Clinical Study: Factors affecting weight and body composition in childhood cancer survivors—cross-sectional study

Abstract | Full Article | PDF Published: 13 Jan 2020 / https://doi.org/10.3332/ecancer.2020.999

Conference Report: Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention

Abstract | Full Article | PDF Published: 13 Jan 2020 / https://doi.org/10.3332/ecancer.2020.998

Review: Cancer prevention programmes in Mexico: are we doing enough?

Abstract | Full Article | PDF | Español Published: 06 Jan 2020 / https://doi.org/10.3332/ecancer.2020.997

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation